Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label management. Show all posts
Showing posts with label management. Show all posts
Wednesday, July 13, 2011

CDC Releases Infection Prevention Guide to Promote Safe Outpatient Care

›
Sunday, April 24, 2011

abstract: Symptom burden in cancer survivors 1 year after diagnosis Cancer

›
CONCLUSIONS: More than 1 in 4 cancer survivors had high symptom burden 1 year postdiagnosis, even after treatment termination. These re...

Apr 2011: free full access - Recognition and initial management of ovarian cancer: summary of NICE guidance -- bmj.com

›
Note: guidelines include Carboplatin alone in high-risk early stage; IP for advanced stage ovarian cancer via clinical trial/s ( which brin...
Saturday, March 26, 2011

Test Results Management (Canadian Patient Safety/College of Physicians & Surgeons Ontario)

›
Saturday, January 15, 2011

full free access: Self-management: Enabling and empowering patients living with cancer as a chronic illness Cancer Jnl

›
Monday, January 10, 2011

National Guideline Clearinghouse | New This Week focus on breast cancer (New Zealand)

›
New Zealand Guidelines Group ...
Friday, December 31, 2010

abstract: Clinical aspects of the management of elderly women diagnosed with gynecologic malignancies: Treatment decisions and choices

›
Thursday, August 19, 2010

Management of Asymptomatic Ovarian and Other Adnexal Cysts Imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement1 — Radiology

›
Note: excellent detailed paper
Sunday, August 15, 2010

Chemotherapy Options in the Management of Platinum-Sensitive Recurrent Ovarian Cancer

›
Note: registration required to view (free) SPECIAL EDITION / EDUCATIONAL REVIEWS ...
Friday, July 09, 2010

full free access: Clinical Care Options Oncology - Clinical Conundrums: Choosing the Best Management Approaches in Patients With Ovarian Cancer (slides)

›
>
Thursday, July 01, 2010

Clinical Management of Borderline Tumours of the Ovary – Experience from the “Berlin Online Tumour Conference for Gynaecological Malignancies” — Anticancer Research

›
Abstract Borderline ovarian tumour (BOT) represents a rare and special tumour entity. Despite a generally favourable prognosis for patient...
Thursday, June 17, 2010

Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies -- Girardi et al., 10.1634/theoncologist.2009-0235 -- The Oncologist

›
Abstract Treatment with the angiogenesis inhibitors bevacizumab, sunitinib, and sorafenib as single agents or in combination with convent...
Friday, June 11, 2010

2010 Institute for Continuing Healthcare Education - Ovarian Cancer Screening and Management to Improve Patient Survival

›
OVERVIEW Ovarian cancer is the leading cause of death from gynecologic malignancy and the fifth leading cause of cancer‐related death amon...
Thursday, June 10, 2010

Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma

›
Note: this issue is important as early-age diagnoses in Lynch Syndrome is common "Approximately one quarter of women diagnosed wit...
Tuesday, May 25, 2010

How Does Older Age Influence Oncologists' Cancer Management? - The Oncologist

›
Reference to ovarian cancer: 10.  Eisenhauer EL, Tew WP, Levine DA et al. Response and outcomes in elderly patients with stages IIIC-IV ova...
Wednesday, May 12, 2010

Clinical relevance of rare germline sequence variants in cancer genes

›
Clinical relevance of rare germline sequence variants in cancer genes: evolution and application of classification models. Abstract Mult...
Tuesday, May 04, 2010

Anti-angiogenesis therapies: their potential in cancer management

›
Note : click on 'pdf' for (free) access to the full paper
Thursday, April 29, 2010

Clinical Update - Ovarian Cancer (commentary - Australia)- Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer ...

›
Note: abstract plus commentary from Australian specialist/Associate Professor Jim Nicklin; includes reference to upcoming trial results
Wednesday, April 21, 2010

Hereditary ovarian cancers: from BRCA mutations to clinical management. A modern appraisal

›

Emerging role of radiotherapy in the management of liver metastases

›